SFI
TCRT icon

SPC Financial Inc’s Alaunos Therapeutics TCRT Stock Holding History

SPC Financial Inc’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-84
Closed -$22K – 209
2022
Q3 		$22K Hold
84
– – ﹤0.01% 188
2022
Q2 		$16K Hold
84
– – ﹤0.01% 189
2022
Q1 		$8K Hold
84
– – ﹤0.01% 188
2021
Q4 		$14K Hold
84
– – ﹤0.01% 190
2021
Q3 		$23K Buy
84
+2
+2% +$612 ﹤0.01% 172
2021
Q2 		$32K Buy
82
+10
+14% +$4.67K ﹤0.01% 167
2021
Q1 		$39K Buy
+72
New +$44.8K 0.01% 165

Other funds holding TCRT

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Addison Capital Conshohocken, Pennsylvania $562M AUM 18.57% 1-Year Est. Return
SGCA
Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

SPC Financial Inc's TCRT Position: Q4 2022 in Review

SPC Financial Inc sold out of Alaunos Therapeutics (TCRT) in Q4 2022, closing a stake of 84 shares — an estimated $22K sold.

SPC Financial Inc first reported a position in TCRT in Q1 2021 and held it in 7 quarters. The position peaked at $39K in Q1 2021. 122 funds tracked by Wall St. Rank hold TCRT as of Q4 2022.

  • SPC Financial Inc reported no remaining Alaunos Therapeutics position as of Q4 2022 after selling out during the quarter.
  • SPC Financial Inc sold 84 Alaunos Therapeutics shares in Q4 2022, an estimated $22K.
  • SPC Financial Inc first reported a position in Alaunos Therapeutics in Q1 2021 and held it in 7 quarters.
  • SPC Financial Inc's Alaunos Therapeutics position peaked at $39K in Q1 2021.
  • 122 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2022.

Based on SPC Financial Inc's 13F filing for Q4 2022, filed 1 Feb 2023.